Population-based study on antenatal corticosteroid treatment in preterm small for gestational age and non-small for gestational age twin infants

References

• Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;(3):CD004454.
   PubMed Web of Science ®Google Scholar
• Blickstein I, Reichman B, Lusky A, et al. Plurality-dependent risk of severe intraventricular hemorrhage among very low birth weight infants and antepartum corticosteroid treatment. Am J Obstet Gynecol 2006;194:1329–33.
   PubMed Web of Science ®Google Scholar
• Blickstein I, Shinwell ES, Lusky A, et al. Plurality-dependent risk of respiratory distress syndrome among very-low-birth-weight infants and antepartum corticosteroid treatment. Am J Obstet Gynecol 2005;192:360–4.
   PubMed Web of Science ®Google Scholar
• Hashimoto LN, Hornung RW, Lindsell CJ, et al. Effects of antenatal glucocorticoids on outcomes of very low birth weight multifetal gestations. Am J Obstet Gynecol 2002;187:804–10.
   PubMed Web of Science ®Google Scholar
• Murphy DJ, Caukwell S, Joels LA, Wardle P. Cohort study of the neonatal outcome of twin pregnancies that were treated with prophylactic or rescue antenatal corticosteroids. Am J Obstet Gynecol 2002;187:483–8.
   PubMed Web of Science ®Google Scholar
• Choi SJ, Song SE, Seo ES, et al. The effect of single or multiple courses of antenatal corticosteroid therapy on neonatal respiratory distress syndrome in singleton versus twin pregnancies. Aust N Z J Obstet Gynaecol 2009;49:173–9.
   PubMed Web of Science ®Google Scholar
• Quist-Therson EC, Myhr TL, Ohlsson A. Antenatal steroids to prevent respiratory distress syndrome: multiple gestation as an effect modifier. Acta Obstet Gynecol Scand 1999;78:388–92.
   PubMed Web of Science ®Google Scholar
• Turrentine MA, Wilson PD, Wilkins IA. A retrospective analysis of the effect of antenatal steroid administration on the incidence of respiratory distress syndrome in preterm twin pregnancies. Am J Perinatol 1996;13:351–4.
   PubMed Web of Science ®Google Scholar
• Boghossian NS, McDonald SA, Bell EF, et al. Association of antenatal corticosteroids with mortality, morbidity, and neurodevelopmental outcomes in extremely preterm multiple gestation infants. JAMA Pediatr 2016;170:593–601.
   PubMed Web of Science ®Google Scholar
• Bernstein IM, Horbar JD, Badger GJ, et al. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000;182:198–206.
   PubMed Web of Science ®Google Scholar
• Torrance HL, Derks JB, Scherjon SA, et al. Is antenatal steroid treatment effective in preterm IUGR fetuses? Acta Obstet Gynecol Scand 2009;88:1068–73.
   PubMed Web of Science ®Google Scholar
• Vidaeff AC, Blackwell SC. Potential risks and benefits of antenatal corticosteroid therapy prior to preterm birth in pregnancies complicated by severe fetal growth restriction. Obstet Gynecol Clin N A 2011;38:205–14. ix.
   PubMed Web of Science ®Google Scholar
• Riskin-Mashiah S, Riskin A, Bader D, et al. Antenatal corticosteroid treatment in singleton, small-for-gestational-age infants born at 24–31 weeks’ gestation: a population-based study. BJOG 2016;123:1779–86.
   PubMed Web of Science ®Google Scholar
• Amiya RM, Mlunde LB, Ota E, et al. Antenatal corticosteroids for reducing adverse maternal and child outcomes in special populations of women at risk of imminent preterm birth: a systematic review and meta-analysis. PLoS One 2016;11:e0147604.
   PubMed Web of Science ®Google Scholar
• Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001;108:E35.
   PubMed Web of Science ®Google Scholar
• Bancalari E, Abdenour GE, Feller R, Gannon J. Bronchopulmonary dysplasia: clinical presentation. J Pediatr 1979;95:819–23.
   PubMed Web of Science ®Google Scholar
• Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529–34.
   PubMed Web of Science ®Google Scholar
• Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1–7.
   PubMed Web of Science ®Google Scholar
• An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol 1984;102:1130–4.
   PubMed Web of Science ®Google Scholar
• Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007;196:147e1–8.
   Google Scholar
• Ancel PY, Goffinet F, Group E-W, et al. Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study. JAMA Pediatr 2015;169:230–8.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Miyazaki K, Ikeda T, et al. The effects of antenatal corticosteroids on short- and long-term outcomes in small-for-gestational-age infants. Int J Med Sci 2015;12:295–300.
   PubMed Web of Science ®Google Scholar
• Garite TJ, Clark R, Thorp JA. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol 2004;191:481–7.
   PubMed Web of Science ®Google Scholar
• Spinillo A, Capuzzo E, Ometto A, et al. Value of antenatal corticosteroid therapy in preterm birth. Early Hum Dev 1995;42:37–47.
   PubMed Web of Science ®Google Scholar
• Schaap AH, Wolf H, Bruinse HW, et al. Effects of antenatal corticosteroid administration on mortality and long-term morbidity in early preterm, growth-restricted infants. Obstet Gynecol 2001;97:954–60.
   PubMed Web of Science ®Google Scholar
• Torrance HL, Mulder EJ, Brouwers HA, et al. Respiratory outcome in preterm small for gestational age fetuses with or without abnormal umbilical artery Doppler and/or maternal hypertension. J Mater-Fetal Neonat Med 2007;20:613–21.
   PubMed Web of Science ®Google Scholar
• van Stralen G, van der Bos J, Lopriore E, et al. No short-term benefits of antenatal corticosteroid treatment in severely preterm growth restricted fetuses: a case-control study. Early Hum Dev 2009;85:253–7.
   PubMed Web of Science ®Google Scholar
• Mitsiakos G, Kovacs L, Papageorgiou A. Are antenatal steroids beneficial to severely growth restricted fetuses? J Mater-Fetal Neonat Med 2013;26:1496–9.
   PubMed Web of Science ®Google Scholar
• Klinger G, Sokolover N, Boyko V, et al. Perinatal risk factors for bronchopulmonary dysplasia in a national cohort of very-low-birthweight infants. Am J Obstet Gynecol 2013;208:115e1–9.
   Web of Science ®Google Scholar
• Reiss I, Landmann E, Heckmann M, et al. Increased risk of bronchopulmonary dysplasia and increased mortality in very preterm infants being small for gestational age. Arch Gynecol Obstet 2003;269:40–4.
   PubMedGoogle Scholar
• Gortner L, Hilgendorff A, Bahner T, et al. Hypoxia-induced intrauterine growth retardation: effects on pulmonary development and surfactant protein transcription. Biol Neonate 2005;88:129–35.
   PubMedGoogle Scholar
• Kugelman A, Reichman B, Chistyakov I, et al. Postdischarge infant mortality among very low birth weight infants: a population-based study. Pediatrics 2007;120:e788–94.
   PubMed Web of Science ®Google Scholar